Showing results (1641-1650 of 1,668) with videos related to

Sort By:
Pageof 167
Immunity|July 21, 2016
A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging GlycansDevin Sok, Matthias Pauthner, Bryan Briney, et al.
Cancer Management and Research|August 22, 2020
Large Scale, Multicenter, Prospective Study of Apatinib in Advanced Gastric Cancer: A Real-World Study from ChinaWanren Peng, Fenglin Zhang, Zishu Wang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 20, 2021
Bandgap Shrinkage and Charge Transfer in 2D Layered SnS2 Doped with V for Photocatalytic Efficiency ImprovementAbhijeet R Shelke, Hsiao-Tsu Wang, Jau-Wern Chiou, et al.
Annals of Translational Medicine|February 8, 2021
A phase III study on neoadjuvant chemotherapy versus neoadjuvant toripalimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909)Yan Zheng, Xian-Ben Liu, Hai-Bo Sun, et al.
JAMA|August 23, 2022
Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical TrialLing-Long Tang, Rui Guo, Ning Zhang, et al.
Plos Pathogens|September 15, 2016
Correction: Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine DesignJoseph G Jardine, Devin Sok, Jean-Philippe Julien, et al.
Plos Pathogens|August 26, 2016
Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine DesignJoseph G Jardine, Devin Sok, Jean-Philippe Julien, et al.
Journal of Clinical Neurology (Seoul, Korea)|January 10, 2026
Efficacy, Safety, and Tolerability of Subcutaneous Efgartigimod PH20 in Chinese Patients With Chronic Inflammatory Demyelinating Polyneuropathy: A Prespecified Subpopulation Analysis of the Multicentre, Randomised-Withdrawal, Double-Blind, Placebo-Controlled, Phase II ADHERE TrialJie Lin, Man Ding, Qinzhou Wang, et al.
Nature|January 11, 2022
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodiesYunlong Cao, Jing Wang, Fanchong Jian, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2013
Immunization of fucose-containing polysaccharides from Reishi mushroom induces antibodies to tumor-associated Globo H-series epitopesShih-Fen Liao, Chi-Hui Liang, Ming-Yi Ho, et al.
Pageof 167